What After the First Propess

NCT02956785 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

85

Enrollment

OTHER

Sponsor class

Stopped Inability to recruit more women because of the COVID-19 and staffing/resources issues

Conditions

Induction of Labor

Interventions

DRUG: 10 mg Dinoprostone; CTS, UK
DRUG: 3 mg Dinoprostone vaginal tablet; Pfizer, UK
DRUG: Aquacryl hydrogel rod; HPSRx Enterprises, USA

Sponsor

South Warwickshire NHS Foundation Trust

Collaborators

[object Object]
[object Object]